Keith Pietropaolo
Chief Tech/Sci/R&D Officer bij ATEA PHARMACEUTICALS, INC.
Profiel
Keith Pietropaolo is currently working as a Senior Vice President-Clinical Operations at Atea Pharmaceuticals, Inc. Prior to his current position, he held the role of Senior Director-Clinical Operations at Sideris Pharmaceuticals, Inc. from 2014 to 2015, and at Idenix Pharmaceuticals LLC from 2003 to 2014.
In 2016, he briefly worked as a Senior Director-Clinical Operations at Alnylam Pharmaceuticals, Inc. Additionally, Mr. Pietropaolo has worked as a Principal at Boston Biostatistics, Inc. Mr. Pietropaolo completed his undergraduate degree at Boston College.
Actieve functies van Keith Pietropaolo
| Bedrijven | Functie | Begin |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Keith Pietropaolo
| Bedrijven | Functie | Einde |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01-12-2016 |
Sideris Pharmaceuticals, Inc.
 Sideris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sideris Pharmaceuticals, Inc. operated as a biopharmaceutical company. It focused on development of therapeutics for the treatment of transfusion related iron overload. The company was founded by Raymond Bergeron and Thomas Neenan on June 1, 2012 and was headquartered in Lexington, MA. | Chief Operating Officer | 01-01-2015 |
| IDENIX PHARMACEUTICALS INC | Corporate Officer/Principal | 01-04-2014 |
| Boston Biostatistics, Inc. | Corporate Officer/Principal | - |
Opleiding van Keith Pietropaolo
| Boston College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ATEA PHARMACEUTICALS, INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Idenix Pharmaceuticals LLC
 Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
Sideris Pharmaceuticals, Inc.
Sideris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sideris Pharmaceuticals, Inc. operated as a biopharmaceutical company. It focused on development of therapeutics for the treatment of transfusion related iron overload. The company was founded by Raymond Bergeron and Thomas Neenan on June 1, 2012 and was headquartered in Lexington, MA. | Health Technology |
| Boston Biostatistics, Inc. |
